Artwork

Content provided by Audio Medica News. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audio Medica News or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

AUDIO JOURNAL OF ONCOLOGY: Randomized Study Found Surgery-Sparing Active Monitoring Safe in Patients With Low-risk DCIS

13:47
 
Share
 

Manage episode 461459396 series 1256601
Content provided by Audio Medica News. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audio Medica News or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

SAN ANTONIO, USA—In patients with hormone receptor-positive, HER2-negative, low-risk ductal carcinoma in situ (DCIS) active monitoring, compared with surgery, resulted in no difference in terms of cancer outcomes in the multicenter, randomized COMET study that compared oncologic outcomes of patients randomized to guideline-concordant care (with surgery alone or with radiation therapy) or active monitoring. COMET investigated 995 patients with grade one or two DCIS with no evidence of invasive cancer.

After reporting the findings at the 2024 San Antonio Breast Cancer Symposium, study author E. Shelley Hwang MD MPH, Breast Surgeon and Director of the Breast Oncology Program at Duke University gave more details to Audio Journal of Oncology Editor, Peter Goodwin:

PODCAST EPISODE:

Audio Journal of Oncology interview with E. Shelley Hwang MD MPH

2024 San Antonio Breast Cancer Symposium ABSTRACT:

GS2-05: Early Oncologic Outcomes Following Active Monitoring or Surgery (+/- Radiation) for Low Risk DCIS: the Comparing an Operation to Monitoring, with or without Endocrine Therapy (COMET) Study (AFT-25)

  continue reading

51 episodes

Artwork
iconShare
 
Manage episode 461459396 series 1256601
Content provided by Audio Medica News. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audio Medica News or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

SAN ANTONIO, USA—In patients with hormone receptor-positive, HER2-negative, low-risk ductal carcinoma in situ (DCIS) active monitoring, compared with surgery, resulted in no difference in terms of cancer outcomes in the multicenter, randomized COMET study that compared oncologic outcomes of patients randomized to guideline-concordant care (with surgery alone or with radiation therapy) or active monitoring. COMET investigated 995 patients with grade one or two DCIS with no evidence of invasive cancer.

After reporting the findings at the 2024 San Antonio Breast Cancer Symposium, study author E. Shelley Hwang MD MPH, Breast Surgeon and Director of the Breast Oncology Program at Duke University gave more details to Audio Journal of Oncology Editor, Peter Goodwin:

PODCAST EPISODE:

Audio Journal of Oncology interview with E. Shelley Hwang MD MPH

2024 San Antonio Breast Cancer Symposium ABSTRACT:

GS2-05: Early Oncologic Outcomes Following Active Monitoring or Surgery (+/- Radiation) for Low Risk DCIS: the Comparing an Operation to Monitoring, with or without Endocrine Therapy (COMET) Study (AFT-25)

  continue reading

51 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Listen to this show while you explore
Play